All About NETs: Disease Pathway, Treatment, and Clinical Trials for GEP-NETs, Pheochromocytoma, and Paragangliomas

Target Audience

This activity is intended for community-based and academic/specialist hematologists, medical oncologists, hematologic oncologists, pathologists, radiologic oncologists, surgical oncologists, primary care providers, oncology nurses and nurse navigators, nurse practitioners, physician assistants, and pharmacists.

Learning Objectives

At the conclusion of this activity, participants will be able to:

Discuss coordination of care and clinical strategies to decrease the time to diagnosis for patients with rare cancers and blood disorders
Integrate patient-centered and evidence-based treatment options for rare cancers and blood disorders
Review emerging therapies under investigation as treatment options
Evaluate management strategies of adverse events to improve patient outcomes
Facilitate informed and shared decision-making through access to disease-related and support resources